Despite strong recommendations for using renin angiotensin system (RAS) inhibitors in patients with stable CAD who do not have heart failure, evidence seems to support a benefit only when these drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback